A new study from Ben-Gurion University of the Negev (BGU) has identified a molecular switch that controls whether stressed human cells activate a survival mechanism or trigger programmed cell death (apoptosis). The findings, published in Redox Biology, provide insights that could help overcome chemotherapy resistance in aggressive tumors.